Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
68.98
-2.71 (-3.78%)
At close: Oct 03, 2025, 3:59 PM
69.10
0.17%
After-hours: Oct 03, 2025, 07:30 PM EDT
13F Institute Ownership
Total Institutes of 559 in Halozyme Therapeutics expanded their positions with an increase of 0 investors compared to the previous quarter. An additional 8.3M shares, as total invested capital declined by $1.56B with ownership percentage increasing from 98.75% to 107.11%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 0.951
0.95
Call Flow 407,800
51%
Put Flow 387,700
49%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Blackrock, Inc. | 10.88% | 13.2M | -22.77% | 686.67M | 0.01% | Aug 12, 2025 |
| Dld Asset Management, LP | 10.30% | 12.5M | +100.00% | 14.31M | 0.81% | Aug 13, 2025 |
| Vanguard Group Inc | 10.09% | 12.25M | -4.57% | 637.02M | 0.01% | Aug 11, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.